New blood clot pill could replace needles for joint replacement patients

NCT ID NCT07124819

First seen Jan 20, 2026 · Last updated May 17, 2026 · Updated 10 times

Summary

This study compared an experimental oral blood thinner (Dimolegin) to standard heparin injections (Clexane) for preventing dangerous blood clots in 215 adults undergoing hip or knee replacement. The goal was to see if the pill works as well as the shot while being easier to take. Results will show how many patients developed clots or bleeding problems in each group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bryansk City Hospital No. 1

    Bryansk, Russia

  • I.M. Sechenov First Moscow State Medical University (Sechenov University)

    Moscow, Russia

  • National Research Ogarev Mordovia State University

    Saransk, Russia

  • Privolzhsky Research Medical University

    Nizhny Novgorod, Russia

  • Rostov State Medical University

    Rostov-on-Don, Russia

  • Ryazan State Medical University named after academician I.P. Pavlov

    Ryazan, Russia

  • Samara Regional Clinical Hospital named after V.D. Seredavin

    Samara, Russia

  • Saratov State Medical University named after V. I. Razumovsky

    Saratov, Russia

Conditions

Explore the condition pages connected to this study.